News

ACR gives guidance on rheumatic disease management during pandemic
- Author:
- Sara Freeman
When COVID-19 is suspected, rheumatic disease patients may continue their hydroxychloroquine but other rheumatic disease treatments may need to be...
News

Cell and gene research raise hopes for recessive dystrophic EB treatments
- Author:
- Sara Freeman
“There are now perhaps as many as a dozen different clinical trials that are in the early stages of trying to find a permanent cure for this...
News

Biologics better solo than with methotrexate in psoriatic arthritis
- Author:
- Sara Freeman
Ustekinumab or a tumor necrosis factor inhibitor are better used alone than with methotrexate in the treatment of psoriatic arthritis.
News
ESMO offers ‘European perspective’ on treating gynecologic cancers during the pandemic
- Author:
- Sara Freeman
ESMO is using a three-tiered system to help clinicians prioritize the care of gynecologic cancer patients during...
News
Managing gynecologic cancers during the COVID-19 pandemic
- Author:
- Sara Freeman
Doctors provide guidance and discuss their experiences managing patients with gynecologic cancers during these challenging times.
News

Cell therapy closes large wounds in epidermolysis bullosa
- Author:
- Sara Freeman
LONDON – Global survey data highlight the negative impact of large wounds, but novel approaches could help chronic open wounds to heal.
News
Genomic prostate score does not improve risk assessment
- Author:
- Sara Freeman
Adding the 17-gene genomic prostate score to common clinical variables did not improve risk stratification...
News
Lopinavir-ritonavir trial results ‘disappointing’ for severe COVID-19
- Author:
- Sara Freeman
But patients in the lopinavir/ritonavir group had a shorter stay in the intensive care unit than did those in the standard-care group.
News
HPV vaccine-chemo combo prolongs cervical cancer survival
- Author:
- Sara Freeman
Longer survival was observed in women with a stronger immune response to human papillomavirus vaccination during chemotherapy.
News
Testing times for epidermolysis bullosa topical therapies
- Author:
- Sara Freeman
LONDON – A number of trials have tested various topical therapies for EB, but none so far has produce the data needed to gain regulatory approval...
News
Breaking bacterial communication may heal EB wounds
- Author:
- Sara Freeman
LONDON – Disrupting how microorganisms communicate with each other could potentially help heal chronic wounds in patients with epidermolysis...
News
Esophageal stricture signals urgent treatment in kids with butterfly skin
- Author:
- Sara Freeman
LONDON – More than a quarter of urgent contacts with a health care professional for generalized-severe recessive...
News
SCC survival remains poor in epidermolysis bullosa
- Author:
- Sara Freeman
LONDON – Median survival was 2.4 years in patients with generalized severe recessive dystrophic epidermolysis bullosa after a first diagnosis.
News

Prioritize oral health in children with DEB
- Author:
- Sara Freeman
LONDON – While it may not be the first thing on the minds of families of children with DEB, it is important to consider oral health early to...
News
Target plantar keratoderma when managing ‘mild’ EBS
- Author:
- Sara Freeman
LONDON – Plantar keratoderma was associated with a vicious circle of pain, reduced mobility, subsequent weight gain, and further foot problems.